Abeona therapeutics announces public offering of common stock and warrants

New york and cleveland, dec. 16, 2021 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a fully-integrated leader in gene and cell therapy, today announced that it intends to offer and sell shares of its common stock and warrants to purchase common stock in an underwritten public offering pursuant to an existing shelf registration statement. all of the securities in the offering are to be sold by abeona. the offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
ABEO Ratings Summary
ABEO Quant Ranking